Feature|Articles|May 21, 2026

The LBAs to Watch for at the 2026 ASCO Meeting

Author(s)Sabrina Serani, Andrea Eleazar, MHS, Jonah Feldman

Preview ASCO 2026 late-breaking cancer trials—from TNBC ADC survival gains to lung, liver, prostate and myeloma readouts shaping care.

The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting kicks off on May 29^th, 2026, in Chicago. This year’s theme is The Science and Practice of Translation: Improving Cancer Outcomes Worldwide, and over 200 presentations will serve to complement. Here, we’ve outlined some of the most anticipated late-breaking abstracts (LBAs) set to be presented during the meeting.